Lanzafame, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 929
AS - Asia 588
EU - Europa 366
SA - Sud America 285
AF - Africa 37
OC - Oceania 11
Totale 2.216
Nazione #
US - Stati Uniti d'America 875
BR - Brasile 235
SG - Singapore 196
CN - Cina 150
IT - Italia 135
VN - Vietnam 134
DE - Germania 53
NL - Olanda 49
GB - Regno Unito 30
MX - Messico 24
ZA - Sudafrica 24
CA - Canada 22
HK - Hong Kong 18
AR - Argentina 17
LV - Lettonia 17
FI - Finlandia 14
FR - Francia 13
IN - India 13
RU - Federazione Russa 12
ID - Indonesia 10
PK - Pakistan 10
TR - Turchia 10
EC - Ecuador 9
JP - Giappone 9
PL - Polonia 9
AU - Australia 8
BD - Bangladesh 8
AT - Austria 7
MA - Marocco 7
PE - Perù 6
ES - Italia 5
IQ - Iraq 5
SA - Arabia Saudita 5
SE - Svezia 5
UA - Ucraina 5
VE - Venezuela 5
CO - Colombia 4
IE - Irlanda 4
PY - Paraguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
KR - Corea 3
NZ - Nuova Zelanda 3
CL - Cile 2
CZ - Repubblica Ceca 2
HN - Honduras 2
MY - Malesia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
PA - Panama 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 2.216
Città #
Dallas 298
Ashburn 136
Singapore 116
Los Angeles 63
Chicago 45
Ho Chi Minh City 45
Amsterdam 38
Beijing 38
Munich 35
São Paulo 26
Trento 26
Hanoi 23
Rome 22
Buffalo 20
Johannesburg 19
Salt Lake City 19
Cavalese 17
Denver 17
Hong Kong 17
Riga 17
New York 16
Cornedo Vicentino 14
Jinan 14
Mexico City 14
Orem 13
Redondo Beach 13
Helsinki 9
Atlanta 8
Elk Grove Village 8
Karachi 8
Tampa 8
Tokyo 8
Verona 8
Warsaw 8
Guangzhou 7
Phoenix 7
Santa Clara 7
Ankara 6
Houston 6
London 6
Manchester 6
Milan 6
Montreal 6
Ziano di Fiemme 6
Belo Horizonte 5
Canoas 5
Da Nang 5
Haiphong 5
Lancaster 5
Rio de Janeiro 5
Salvador 5
Stockholm 5
Wilmington 5
Can Tho 4
City of London 4
Curitiba 4
Hefei 4
Hải Dương 4
Istanbul 4
Mumbai 4
Poplar 4
Roverbella 4
Tashkent 4
Toronto 4
Turku 4
Aparecida de Goiânia 3
Baghdad 3
Boston 3
Brooklyn 3
Cairo 3
Chennai 3
Dublin 3
Guayaquil 3
Lima 3
Lissone 3
Miami 3
Moscow 3
Nuremberg 3
Porto Alegre 3
Querétaro 3
Quảng Ngãi 3
Seattle 3
Thái Nguyên 3
Affi 2
Bismarck 2
Boardman 2
Bogotá 2
Bom Despacho 2
Brisbane 2
Cachoeirinha 2
Campinas 2
Cao Lanh 2
Ciudad del Este 2
Cologno Monzese 2
Cuiabá 2
Detroit 2
Dongguan 2
Duque de Caxias 2
Engativá 2
Fortaleza 2
Totale 1.430
Nome #
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral Treatment 111
Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure 85
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol 80
Uso degli antibiotici nel fine vita 71
Breastfeeding in women living with HIV in high-income countries: It's time to act 67
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 65
A multicentre real-life prospective cohort study on effectiveness, durability and safety of long-acting injectable cabotegravir and rilpivirine in northern Italy: the LONGITUDE study 57
Primary cutaneous cryptococcosis in a HIV infested patient: case report 54
When an underestimated zoonosis and antimicrobial resistance collide: Corynebacterium ulcerans 54
Recurrent UTI: Questions and Answers on Clinical Practice 50
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 50
HIV screening of migrants in the autonomous Province of Trento (North-Eastern Italy) 48
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 47
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer 47
Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report 46
High malaria parasitemia in an Italian man and severe delayed hemolytic anemia 46
Bridging the gap in bloodstream infection management: a survey among non-infectious disease physicians 42
Benign acute viral myositis in African migrants: a clinical, serological and pathological study 40
Emerging strategies in tackling antimicrobial resistance in urology: Narrative review and expert opinion 35
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs―Experience From Northern Italy 35
A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients 34
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report 34
A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients 34
Klebsiella pneumoniae resistant to carbapenems: bloodstream infection prevalence before and during the SARS-CoV-2 pandemic in a tertiary level, North-Eastern Italian Hospital 33
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 32
Adherence to HAART in HIV 32
Mini-review: Silico-tuberculosis 32
Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience 31
. Raltegravir plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-positive Patients: Safety, Efficacy and Pharmacokinetics 29
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab 29
Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities 28
Antiretroviral therapy in low-resource settings 28
Aetiology of pneumonia following isolated closed head iniury 27
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 27
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study 27
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 26
"High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART 24
Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study 24
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 24
Antiretroviral therapy-associated diseases are common in the long-term 23
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation 23
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 23
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 22
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 22
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection 21
Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up 19
Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients 19
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study 17
HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa 17
Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections? 17
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States 15
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 14
Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study 14
Efavirenz dose reduction in HIV-infected patients 14
Meningite da Escherichia Coli in una persona con infezione da HIV; descrizione di un caso clinico e revisione della letteratura = Escherichia Coli meningitis in a person living with HIV infection: a clinical case and review of the literature. 14
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 13
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 13
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice. 12
Successful Treatment of Castleman's Disease with HAART in two HIV-infected patients. 12
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 12
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients 11
Patient-centered Care and Treatment in HIV Infection 11
HIV treatment default in sub-Saharan Africa: issues and possible solutions 11
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 10
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study) 9
“Terapia intermittente” con bictegravir/emtricitabina/tenofovir alafenamide in una piccola coorte di pazienti con infezione da HIV, virologicamente soppressi = Short cycle therapy with bictegravir/emtricitabine/tenofovir alafenamide in a small cohort of virally suppressed people living with HIV. 9
Can antiretroviral therapy be safely interrupted and, if so, when? 8
Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA? 8
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 8
The burden and epidemiology of community-acquired central nervous system infections: a multinational study 8
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting 8
Dolutegravir Monotherapy's Virological Efficacy in a Highly Treatment-Experienced Patient 8
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy 7
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 7
Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV 7
Voluntary or Universal HIV testing in Italy? 7
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 7
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy 7
Sindrome lipodistrofica in un paziente con infezione da hiv,trattato con pentoxifillina 7
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 7
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 7
Tuberculosis-immune reconstitution inflammatory syndrome 7
DRIVE-AHEAD Trial's Results and the Need for a More Appropriate Comparator Drug 6
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report 6
Influenza dell’attività fisica sul valore ematico dei lipidi in una piccola coorte di pazienti che vivono con infezione da HIV, soppressi e dislipidemici, dopo lo switch da un regime contenente tenofovir alafenamide a dolutegravir/rilpivirina = Influence of physical activity level on serum lipid values in a small cohort of suppressed dyslipidemic people living with HIV after switching from a tenofovir alafenamide regimen to dolutegravir/rilpivirine. 6
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection 6
Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery 6
Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy 6
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 6
Comparative evaluation of naturally occuring Pneumocystis carinii pneumonia(PCP) and PCP despite primary chemoprophylaxis in patients with AIDS 6
Inflammatory pseudotumor of lymph nodes 6
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 6
Long -term efficacy of dual nucleoside transcriptase inhibitor antiretroviral therapy in HIV-1 infection 5
Computational characterization of peptide binding stability to HLA-C allotypes and its association with HIV-1 infection progression and HIV-1 related neurocognitive impairment. 5
Socio-demographic Characteristics, Sexual and Test-Seeking Behaviours Amongst Men Who have Sex with Both Men and Women: Results from a Bio-behavioural Survey in 13 European Cities 5
Optimal fosamprenavir regimen to prevent lipid abnormalities. 5
Raltegravir/nevirapine dual therapy at reduced doses as ‘maintenance' treatment in virally suppressed HIV-infected patients 5
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium Falciparum malaria 5
Esophageal Cryptococcosis in a patient with AIDS 5
Toxic epidermal necrolysis induced by nevirapine therapy: description of two cases and review of the literature 5
Totale 2.320
Categoria #
all - tutte 8.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025303 0 0 0 0 0 0 0 0 1 180 34 88
2025/20262.203 113 157 587 599 621 126 0 0 0 0 0 0
Totale 2.506